Evidence map›Paper›PMID 32492924›Full record

ReviewInternational journal of molecular sciences2020

S100A6 and Its Brain Ligands in Neurodegenerative Disorders.

Anna Filipek, Wiesława Leśniak

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. S100A6 Protein-Expression and Function in Norm and Pathology.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anna FilipekNencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland.
Wiesława LeśniakNencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland.
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego · PL

Funding

Narodowe Centrum Nauki 2018/29/B/NZ4/01384Nencki Institute of Experimental Biology Statutory funds
6 · The paper itself

Abstract

The S100A6 protein is present in different mammalian cells and tissues including the brain. It binds Ca

Indexed as

Amyotrophic Lateral SclerosisAnimalsAstrocytesBrainCalciumCalcium-Binding ProteinsCell Cycle ProteinsEpilepsyGene Expression RegulationHumansHuntington DiseaseLigandsMiceNeurodegenerative DiseasesNeuronsParkinson DiseaseCACYBP protein, humanCalciumCalcium-Binding ProteinsCell Cycle ProteinsLigandsS100A6 protein, humanS100 Calcium Binding Protein A6SUGT1 protein, humanCacyBP/SIPLewy bodiesneurodegenerationneurofibrillary tanglesS100A6Sgt1β amyloid plaques

Identifiers

PMID32492924
PMCPMC7313082
OpenAlexW3029766797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.